Brief: BioNTech Says CureVac Shareholders Are Advised To Tender Their Shares By 6:00 P.M. Eastern Time On Tuesday, December 2, 2025
26/11/2025 12:33
Nov 26 (Reuters) - BIONTECH SE 22UAy.DE:
ANNOUNCED APPROVAL OF MATTERS RELATING TO EXCHANGE OFFER ( "OFFER") FOR ALL OUTSTANDING SHARES OF CUREVAC N.V. (NASDAQ: CVAC, "CUREVAC") AT EXTRAORDINARY GENERAL MEETING ("EGM") HELD BY CUREVAC ON NOVEMBER 25, 2025
CUREVAC SHAREHOLDERS ARE ADVISED TO TENDER THEIR SHARES BY 6:00 P.M. EASTERN TIME ON TUESDAY, DECEMBER 2, 2025
Source text: ID:nGNE1jQ09M
Further company coverage: [22UAy.DE]
(Gdansk Newsroom)
((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))
Recent news on CureVac NV
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Biontech Closes Acquisition Of CureVac
Brief: BioNTech Says CureVac Shareholders Are Advised To Tender Their Shares By 6:00 P.M. Eastern Time On Tuesday, December 2, 2025
Brief: Curevac Reaffirms Its Expected Cash Runway Into 2028